At NIZO, we accelerate innovation in health and well‑being through advanced microbiome research. Our expertise covers the full development chain — from selecting and characterizing probiotic strains to ensuring their manufacturability at scale. With state‑of‑the‑art facilities and deep experience in intestinal commensals, we help partners unlock the full potential of probiotics for high‑impact products.
NIZO experts Jolanda Lambert, Segment Lead Health & Nutrition, and Ioana Iorga, Strategic Sales Manager, will attend the Microbiome R&D and Business Collaboration Forum, taking place 11–12 May 2026 in Rotterdam, The Netherlands.
Jolanda will present “Lessons From 15 Years of Innovation” on Day 1 at 12:00 AM.

Successfully development of health-promoting food and ~biotics ingredients requires an integrated, multi-step strategy encompassing AI-supporting high-throughput screening, in vitro and in vivo benefit verification, and early regulatory and manufacturability assessments. Because each stage demands specialize expertise and incurs significant time and costs, adopting a holistic, end-to-end approach substantially increases the likelihood of technical and commercial success. In her presentation, Jolanda highlighted several of these critical topics, illustrating how an integrated innovation approach can support successful product development.
Both experts will be available throughout the conference. If you would like to discuss your project ideas, explore collaboration opportunities, or learn how NIZO can support your development pipeline, you can make an appointment directly with Ioana or Jolanda.